Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,531Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Pharmathen SA

02 3APGDI

03 2Alkem Laboratories

04 2Apotex Inc

05 19Astellas Pharma

06 1Aurobindo Pharma Limited

07 2KMS Health Center

08 2Lupin Ltd

09 2QILU PHARMACEUTICAL CO., LTD.

10 1Sawai Pharmaceutical Co

11 2Tecnimede

12 2Unichem Laboratories Limited

13 1Whanin Pharmaceutical

14 2Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Bio-Europe Spring
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Mirabegron

Brand Name :

Dosage Form : Prolonged Release Tablet

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

02

arrow
Bio-Europe Spring
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Mirabegron

Brand Name :

Dosage Form : Prolonged Release Tablet

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

03

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2024-02-12

Application Number : 215948

Regulatory Info : RX

Registration Country : USA

blank

04

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2024-02-12

Application Number : 215948

Regulatory Info : RX

Registration Country : USA

blank

05

APGDI

U.S.A
Bio-Europe Spring
Not Confirmed
arrow

APGDI

U.S.A
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2012-06-28

Application Number : 202611

Regulatory Info : RX

Registration Country : USA

blank

06

APGDI

U.S.A
Bio-Europe Spring
Not Confirmed
arrow

APGDI

U.S.A
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2012-06-28

Application Number : 202611

Regulatory Info : RX

Registration Country : USA

blank

07

APGDI

U.S.A
Bio-Europe Spring
Not Confirmed
arrow

APGDI

U.S.A
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ GRANULES

Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG/ML

Packaging :

Approval Date : 2021-03-25

Application Number : 213801

Regulatory Info : RX

Registration Country : USA

blank

08

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2025-01-02

Application Number : 209434

Regulatory Info : RX

Registration Country : USA

blank

09

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-01-02

Application Number : 209434

Regulatory Info : RX

Registration Country : USA

blank

10

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 50 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

11

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 25 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

12

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 25 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 25 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 50 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

15

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 50 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

16

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

Mirabegron

Brand Name : Betmiga

Dosage Form : Depottablett

Dosage Strength : 50 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

17

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 209413

Regulatory Info :

Registration Country : USA

blank

18

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

Mirabegron

Brand Name :

Dosage Form : Tablet

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

19

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

Mirabegron

Brand Name :

Dosage Form : Tablet

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

20

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2022-09-28

Application Number : 209485

Regulatory Info : RX

Registration Country : USA

blank

21

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2022-09-28

Application Number : 209485

Regulatory Info : RX

Registration Country : USA

blank

22

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2019-12-27

Application Number : 209446

Regulatory Info : DISCN

Registration Country : USA

blank

23

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Mirabegron

Brand Name :

Dosage Form : Prolonged Release Tablets

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Portugal

blank

24

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Mirabegron

Brand Name :

Dosage Form : Prolonged Release Tablets

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Portugal

blank

25

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Mirabegron

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

26

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Mirabegron

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

27

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2022-09-29

Application Number : 209488

Regulatory Info : RX

Registration Country : USA

blank

28

Bio-Europe Spring
Not Confirmed
arrow
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2022-09-29

Application Number : 209488

Regulatory Info : RX

Registration Country : USA

blank

29

QILU PHARMACEUTICAL CO., LTD.

Country
Bio-Europe Spring
Not Confirmed
arrow

QILU PHARMACEUTICAL CO., LTD.

Country
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 217989

Regulatory Info :

Registration Country : USA

blank

30

QILU PHARMACEUTICAL CO., LTD.

Country
Bio-Europe Spring
Not Confirmed
arrow

QILU PHARMACEUTICAL CO., LTD.

Country
arrow
Bio-Europe Spring
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 217989

Regulatory Info :

Registration Country : USA

blank